zalcitabine has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamzeh, FM; Lewis, LD; Lietman, PS | 1 |
| Sommadossi, JP; Weidner, DA | 1 |
2 other study(ies) available for zalcitabine and Di Guglielmo Disease
| Article | Year |
|---|---|
Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine.
Topics: Cells, Cultured; DNA, Mitochondrial; Lactates; Leukemia, Erythroblastic, Acute; Microscopy, Electron; Mitochondria; Tumor Cells, Cultured; Zalcitabine | 1992 |
3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
Topics: Anemia; Butyrates; Butyric Acid; Dose-Response Relationship, Drug; Globins; Hemoglobins; Humans; Leukemia, Erythroblastic, Acute; Protein Biosynthesis; Transcription, Genetic; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1990 |